Physician profile
Brandon D Workman
NPI 1598218026
$2,024.52
in general payments reported to CMS, 2019-2025
20 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,297 · 2022: $225 · 2023: $29.66 · 2024: $270 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $596.95 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Esperion Therapeutics, INC. | $328.17 | 2021-2024 | Nexletol |
| Abbvie INC. | $156.08 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.12 | 2021-2025 | Jardiance, Synjardy |
| Amgen INC. | $106.68 | 2024-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $106.08 | 2021-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $88.72 | 2021-2025 | Airsupra |
| Glaxosmithkline, LLC. | $74.96 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.18 | 2021 | |
| Amarin Pharma, INC. | $65.95 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.31 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $47.68 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $34.48 | 2021 | |
| Horizon Therapeutics Plc | $33.76 | 2021 | |
| Novartis Pharmaceuticals Corporation | $28.76 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.56 | 2024 | Cologuard Collection Kit |
| Antares Pharma, INC. | $18.95 | 2021 | |
| Pfizer INC. | $16.46 | 2021 | |
| Endo Pharmaceuticals INC. | $13.90 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.